AUSTIN, TEXAS — February 12, 2019 — Signature Science, LLC has been awarded a contract from the Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in support of the Multi-Phase Chemical Agent Detector (MPCAD) program. The Other Transaction Authority (OTA) award is... MORE
Dr. Turner will apply his informatics and genomics expertise to the development of leading-edge forensic genomics solutions for national security, defense, and law enforcement challenges, such as cold case investigations. AUSTIN, TEXAS — Feb. 5, 2019 - Signature Science, LLC is pleased to announce that Dr. Stephen Turner has joined... MORE
SigSci Awarded a CDC Contract to Study Simulated Pathogen Transmission in Healthcare Settings Using Metagenomic...
Researchers from Signature Science will evaluate and develop tools which can detect and follow the spread of specific bacteria and microbial communities between people and across surfaces in healthcare settings. AUSTIN, TEXAS — Nov. 27, 2018 — The Centers for Disease Control and Prevention (CDC) has awarded Signature Science, LLC... MORE
SigSci Awarded $2.3M IARPA Contract to Develop Novel Forensic Identification Methods that Sequence Protein Instead...
AUSTIN, TEXAS — August 08, 2018 — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic... MORE
Austin, Texas – September 21, 2017 – The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC a $2.9M contract for the development of new computational tools to screen DNA sequences to detect biological threats that may manifest from synthetic microbial manipulation. The challenge is to overcome the speed... MORE